Total Payments
$1,208
2024 Payments
$401.62
Companies
13
Transactions
47
Medicare Patients
20,628
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$1,208 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,208 | 47 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $295.65 | 12 | $0 (2024) |
| ABBVIE INC. | $234.14 | 13 | $0 (2024) |
| GENZYME CORPORATION | $159.68 | 4 | $0 (2024) |
| Celgene Corporation | $137.56 | 3 | $0 (2018) |
| UCB, Inc. | $95.66 | 3 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $69.82 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $61.32 | 3 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $49.47 | 2 | $0 (2024) |
| Amgen Inc. | $40.11 | 2 | $0 (2024) |
| Biofrontera Inc. | $18.66 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $401.62 | 21 | ABBVIE INC. ($217.23) |
| 2023 | $120.31 | 6 | Janssen Biotech, Inc. ($43.77) |
| 2021 | $49.36 | 3 | Novartis Pharmaceuticals Corporation ($49.36) |
| 2020 | $49.21 | 3 | Biofrontera Inc. ($18.66) |
| 2019 | $141.13 | 5 | Novartis Pharmaceuticals Corporation ($91.13) |
| 2018 | $290.36 | 5 | GENZYME CORPORATION ($100.57) |
| 2017 | $156.30 | 4 | Celgene Corporation ($82.56) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $18.50 | General |
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, EBGLYSS | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Immunology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $32.76 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.20 | General |
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Inflammation | ||||||
| 07/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Immunology | ||||||
| 07/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: IMMUNOLOGY | ||||||
| 06/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Immunology | ||||||
| 06/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: IMMUNOLOGY | ||||||
| 05/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: IMMUNOLOGY | ||||||
| 05/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: IMMUNOLOGY | ||||||
| 04/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Immunology | ||||||
| 04/15/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.94 | General |
| 03/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Immunology | ||||||
| 02/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.71 | General |
| Category: Immunology | ||||||
| 09/26/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Immunology | ||||||
| 09/14/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 5,034 | 21,215 | $622,610 | $405,281 |
| 2022 | 35 | 4,879 | 23,106 | $602,759 | $392,894 |
| 2021 | 34 | 5,375 | 23,503 | $656,579 | $430,544 |
| 2020 | 34 | 5,340 | 29,419 | $607,792 | $404,510 |
Total Patients
20,628
Total Services
97,243
Medicare Billing
$1.6M
Procedure Codes
136
All Medicare Procedures & Services
136 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 935 | 1,392 | $126,927 | $80,374 | 63.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,228 | 2,075 | $74,352 | $55,752 | 75.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 289 | 436 | $75,591 | $51,948 | 68.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 694 | 930 | $63,570 | $33,437 | 52.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 657 | 5,748 | $39,370 | $28,321 | 71.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 287 | 339 | $39,126 | $24,389 | 62.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 61 | 64 | $20,061 | $14,512 | 72.3% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 110 | 131 | $18,398 | $11,366 | 61.8% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 30 | 8,800 | $14,796 | $11,300 | 76.4% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 29 | 31 | $14,862 | $11,267 | 75.8% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 101 | 119 | $14,899 | $9,315 | 62.5% |
| 96900 | Application of ultraviolet light to skin | Office | 2023 | 12 | 462 | $11,451 | $8,338 | 72.8% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 12 | 23 | $8,990 | $7,048 | 78.4% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 66 | 83 | $11,596 | $6,978 | 60.2% |
| 11312 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 53 | 56 | $8,919 | $6,238 | 69.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 48 | $6,160 | $4,399 | 71.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 33 | 38 | $6,888 | $4,198 | 60.9% |
| 11307 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 41 | 43 | $6,095 | $4,182 | 68.6% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 43 | 47 | $6,004 | $3,948 | 65.8% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 35 | 37 | $10,060 | $3,943 | 39.2% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 15 | 15 | $4,729 | $3,708 | 78.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 36 | 36 | $9,193 | $3,351 | 36.4% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 13 | 13 | $4,468 | $3,150 | 70.5% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 11 | 16 | $4,556 | $3,041 | 66.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $5,298 | $3,022 | 57.0% |
About Dr. Thomas George, MD
Dr. Thomas George, MD is a Dermatology healthcare provider based in Kalispell, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336207430.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas George, MD has received a total of $1,208 in payments from pharmaceutical and medical device companies, with $401.62 received in 2024. These payments were reported across 47 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,208).
As a Medicare-enrolled provider, George has provided services to 20,628 Medicare beneficiaries, totaling 97,243 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 136 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Kalispell, MT
- Active Since 12/04/2006
- Last Updated 01/04/2008
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1336207430
Products in Payments
- COSENTYX (Biological) $277.71
- SKYRIZI (Biological) $153.05
- Otezla (Drug) $149.12
- DUPIXENT (Drug) $100.57
- Tremfya (Drug) $69.82
- RINVOQ (Biological) $62.59
- TREMFYA (Drug) $61.32
- DUPIXENT (Biological) $59.11
- Cimzia (Drug) $50.00
- Sotyktu (Drug) $49.47
- Bimzelx (Biological) $45.66
- AMELUZ (Drug) $18.66
- TALTZ (Drug) $15.53
- BOTOX COSMETIC (Biological) $14.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Kalispell
Ann Brewer, M.d, M.D
Dermatology — Payments: $4,738
Dermatology $4,738
Kathryn Hansen, Md, MD
Dermatology — Payments: $4,448
Dermatology $4,448
Sylvia Owen, Md, MD
Dermatology — Payments: $769.66
Dermatology $769.66
Ellen Franciosi, Md, MD
Dermatology — Payments: $85.94
Dermatology $85.94
George Mclean, Md, MD
Dermatology
Dermatology
David Murdock, Md, MD
Dermatology
Dermatology